Sat.Jun 20, 2020 - Fri.Jun 26, 2020

article thumbnail

Intouchers Win Big in the Hedera20 Hackathon

Intouch Solutions

The pandemic couldn't stop a group of Intouchers who banded together (apart) to compete in Hedera20, a global, virtual hackathon. They created HumanKind, an app that encourages and rewards acts of kindness. The post Intouchers Win Big in the Hedera20 Hackathon appeared first on Intouch Solutions.

97
article thumbnail

Identifying & Coping With Agitation In Alzheimer’s Dementia Patients

Olympian Clinical Research

June is National Alzheimer’s and Brain Awareness Month , and as we wrap up a month spent advocating for patients with Alzheimer’s and raising awareness about the signs, symptoms, and management of this horrible disease, we want to take some time to highlight a part of Alzheimer’s that many people don’t talk about, agitation or aggression related to Alzheimer’s dementia. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lab Manager Ask the Expert

Drug Patent Watch

Check out the latest issue of Lab Manager where I discuss my interest in informatics, the complexities of informatics for today’s scientists, and some of the tools available. [link]. The post Lab Manager Ask the Expert appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

PI and CRC Fee Justification On A Clinical Research Site Budget

Clinical Trial Gurus

Sites have historically absorbed the costs associated with research which are not included in the schedule of events. These costs are often overlooked but can include anything ranging from analyzing blood results, following up with vendors, or answering CRA emails with intricate requests. One way to mitigate the amount of time spent on such tasks is to include a PI and CRC fee on the site’s budget.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Physicians Remain Hesitant to See Reps

Intouch Solutions

Healthcare professionals are still uncomfortable with the thought of seeing pharmaceutical sales reps in person. While in-person rep visits will decline, opportunities abound for brands. The post Physicians Remain Hesitant to See Reps appeared first on Intouch Solutions.

article thumbnail

Accelerating your digital IQ for the next normal of customer engagement

pharmaphorum

COVID-19 has brought many changes to the pharmaceutical industry, among them a need to change how pharma companies engage with HCPs and transform their approach to digital channels. This webinar, held in association with Veeva, will present some exclusive market observations from before and during the COVID crisis and explain how pharmaceutical companies can increase their digital IQ and accelerate the move to digital.

More Trending

article thumbnail

Career Development Bonus CRA Academy Session With Guest Clinical Research Associate Victoria Welch

Clinical Trial Gurus

A CRA shares her story about how she was able to go from coordinator to CRA after graduating from her university. She also provides some useful tips for getting noticed by potential employers and eventually getting hired. One of the things that she recommends and goes into detail about using is LinkedIn as a great platform for networking.

article thumbnail

7 Staff Augmentation Resources to Help Your Site Restart Research

Forte Research Systems®

With research activities gradually resuming, research teams may be challenged with conducting their trials effectively and efficiently. Here’s how Staff Augmentation can help.

article thumbnail

Trying To Become a CRA During a Pandemic

ECRG Media's Clinical Research Podcast

Trying to Become a CRA During A Pandemic Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Send in a v

article thumbnail

Unlocking health data to improve oncology outcomes

pharmaphorum

As use of real-world evidence increases there is an opportunity to improve the patient experience. In addition to key steps forward with the establishment of Health Data Research UK and NHSX, information governance will be key, as is alignment to UK and EU regulations such as the July 2019 DHSC Framework for the Value of NHS Research and GDPR.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

DrugPatentWatch and Bloomberg: Are there too many generic patent challenges?

Drug Patent Watch

Check out this Bloomberg Law article where DrugPatentWatch shows how the number of patent challenges is increasing, while the number of challengers of each patent is also increasing. Why might this…. The post DrugPatentWatch and Bloomberg: Are there too many generic patent challenges? appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Q&A: The New Normal: Considerations for Restarting Research

Forte Research Systems®

In a recent webinar, Advarra IRB and research compliance experts discussed key areas to consider when ramping up research in the COVID-19 pandemic’s “new normal.”.

article thumbnail

Trying To Become a CRA During a Pandemic

ECRG Media's Clinical Research Podcast

Trying to Become a CRA During A Pandemic. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.

article thumbnail

Federal Courts begin to phase out the Suspension Period

Pharma in Brief

On June 11, 2020 the Federal Court ( FC ) and Federal Court of Appeal ( FCA ) published updated notices to gradually phase out the Suspension Period, which had previously been extended to June 15, 2020. Federal Court. The FC’s June 11, 2020 Practice Direction and Order ( Updated Order ), amends its previous Practice Directions, which, subject to the amendments listed, continue to remain in force.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

What I Learned as a Clinical Research Associate That I Didn't Know as a Site Owner

Clinical Trial Gurus

Inexperienced site owners can easily fall into the trap of thinking that their monitors are trying to find as many errors as possible from their site. In this video, Dan Sfera recounts the different interactions that he has had with monitors and assures sites that the reality is that monitors are not trying to tarnish a site’s reputation. Most monitors are actually trying to complete their reports and are more than willing to work with sites to reduce the number of findings at each visit.

article thumbnail

Treatment of cystitis over the counter

Druggist

Cystitis is a common condition mainly affecting women; however, it can also affect men and children. Mild cystitis is usually a self-limiting condition, meaning it will go on its own. Some patients may need to see their GP, depending on symptoms and their duration. Treatment of cystitis over the counter involves pain management with commonly available analgesics and the symptomatic management with products available from a pharmacy and other stores.

article thumbnail

Transatlantic Drug Regulatory Cooperation: Moving Beyond Canada

Pharmacy Checkers

Canada is a good option for Americans seeking to access their medications at a lower cost through personal drug importation , but even I agree with the pharmaceutical industry when they say that wholesale drug importation on a large scale is not workable with Canada. Why? Simply because Canada is too small a nation to supply the U.S. market. I have written that there is much more promise if importation is expanded to the European Union.

Drugs 55
article thumbnail

PMPRB launches consultation on revised Draft Guidelines

Pharma in Brief

On June 19, 2020, the Patented Medicine Prices Review Board ( PMPRB ) launched its consultation on revised Draft Guidelines to implement the amended Patented Medicines Regulations. The revised Guidelines outline new price tests for existing and new patented medicines, as well as a revised risk-based system for reporting and investigations. They will be available for public comment until July 20, 2020.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.